Latest News & Features
Americas
Generic drug makers Mylan and Teva were afforded victory earlier this week when the US Court of Appeals for the Federal Circuit affirmed the invalidation of four patents owned by biotech company Acorda Therapeutics. 12 September 2018
Americas
Medical device maker Fisher & Paykel Healthcare filed a complaint with the US International Trade Commission yesterday against rival ResMed. 12 September 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday revived a patent infringement lawsuit against Teva Pharmaceuticals, in a win for Sweden-based Orexo. 11 September 2018
Americas
The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology. 11 September 2018
Americas
Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar. 10 September 2018
Americas
Seven states have urged the US Court of Appeals for the Federal Circuit to rehear a decision rejecting the use of tribal sovereign immunity in the inter partes review process. 10 September 2018
Biotechnology
Biotech company Shire yesterday revealed plans to acquire a Switzerland-based plasma collection company. 7 September 2018
Americas
The misuse of federal drug programmes by branded pharmaceutical companies is costing the US healthcare system $13.4 billion per year in lost savings, a report commissioned by a generics trade group has claimed. 6 September 2018
Americas
Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million. 6 September 2018
Americas
US-based Gilead announced Tuesday, September 4 that it has entered into a licensing agreement with biotech company Trianni for an undisclosed sum. 6 September 2018